EnVVeno Medical Corporation (NASDAQ:NVNO)

PRESS RELEASE

published on 04/16/2024 at 15:00, 2 years 5 months ago

New Topline Efficacy Data from the enVVeno Medical VenoValve(R) Pivotal Trial to be Presented at the 46th Annual Charing Cross Symposium on April 24, 2024
enVVeno Medical Corporation to present additional topline efficacy data from VenoValve U.S. pivotal trial at 2024 Charing Cross International Symposium in London. Data to review clinical status of severe Chronic Venous Insufficiency patients post VenoValve implantation

VenoValve Chronic Venous Insufficiency EnVVeno Medical Corporation SAVVE Trial Charing Cross International Symposium
BRIEF

published on 04/09/2024 at 14:50, 2 years 5 months ago

EnVVeno Medical Appoints Andrew Cormack as Chief Commercial Officer to Spearhead VenoValve® Commercialization

EnVVeno Medical VenoValve® Chronic Venous Insufficiency (CVI) SAVVE U.S. Pivotal Study Commercialization Strategy
BRIEF

published on 04/09/2024 at 14:50, 2 years 5 months ago

EnVVeno Medical nomme Andrew Cormack au poste de directeur commercial pour diriger la commercialisation de VenoValve®

EnVVeno Medical VenoValve® Insuffisance Veineuse Chronique (IVC) Étude Pivot Américaine SAVVE Stratégie De Commercialisation
PRESS RELEASE

published on 04/09/2024 at 14:45, 2 years 5 months ago

enVVeno Medical Appoints Andrew Cormack as Its Chief Commercial Officer
enVVeno Medical Corporation appoints Andrew Cormack as Chief Commercial Officer to drive VenoValve's commercialization strategy. PMA application for FDA approval on track for Q4 2024

FDA Approval VenoValve EnVVeno Medical Corporation Commercialization Strategy Andrew Cormack
BRIEF

published on 03/15/2024 at 14:05, 2 years 6 months ago

EnVVeno Medical to Showcase Its Innovations in an Upcoming Virtual Investor Event

EnVVeno Medical Medical Innovation Virtual Investor Event Venous Disease Treatment Corporate Overview
BRIEF

published on 03/15/2024 at 14:05, 2 years 6 months ago

EnVVeno Medical présentera ses innovations lors d'un prochain événement virtuel pour les investisseurs

Innovation Médicale EnVVeno Medical Événement Virtuel Pour Les Investisseurs Traitement Des Maladies Veineuses Vue D'ensemble De L'entreprise
PRESS RELEASE

published on 03/15/2024 at 14:00, 2 years 6 months ago

enVVeno Medical to Participate in the Virtual Investor Lunch Break: The enVVeno Opportunity
enVVeno Medical to present at Virtual Investor Lunch Break on March 21, 2024, with CEO Robert Berman discussing the company's outlook and the enVVeno Opportunity

EnVVeno Medical Venous Disease Treatment Virtual Investor Lunch Break Robert Berman Bioprosthetic Solutions
BRIEF

published on 03/06/2024 at 14:45, 2 years 6 months ago

EnVVeno Medical Corporation Announces Positive Results from VenoValve Pivotal Trial

FDA Approval EnVVeno Medical VenoValve Chronic Venous Insufficiency Clinical Improvement
BRIEF

published on 03/06/2024 at 14:45, 2 years 6 months ago

EnVVeno Medical Corporation annonce les résultats positifs de l'essai pivot VenoValve

EnVVeno Medical Insuffisance Veineuse Chronique VenoValve Approbation De La FDA Amélioration Clinique
PRESS RELEASE

published on 03/06/2024 at 14:40, 2 years 6 months ago

Positive Topline Efficacy Data Showing Significant Clinical Improvement from enVVeno Medical’s VenoValve(R) Pivotal Trial to be Presented Today at the VENOUS2024 American Venous Forum Annual Meeting
enVVeno Medical presents positive topline efficacy data from the SAVVE U.S. pivotal trial for the VenoValve at the 2024 American Venous Forum Annual Meeting, showing significant clinical improvement in CVI patients

EnVVeno Medical VenoValve Clinical Improvement SAVVE Trial CVI Patients

Published on 09/19/2026 at 00:55, 2 days 5 hours ago

Gossan Resources Announces Changes to Board and Management
Published on 09/18/2026 at 23:50, 2 days 6 hours ago

Mako Mining Announces Equity Incentive Grants
Published on 09/18/2026 at 22:00, 2 days 8 hours ago

Silver Tiger Announces Results of Annual and Special Meeting
Published on 09/18/2026 at 20:35, 2 days 9 hours ago

Only 11% of Marketers Expect Google Search to Be Their Customers' Main Starting Point in Two Years
Published on 09/18/2026 at 14:30, 2 days 15 hours ago

AIAI Holdings to Obtain a Controlling Position in Messier 42 Marketing Agreement

View all ACCESSWIRE

Published on 09/21/2026 at 04:15, 2 hours 5 minutes ago

Eureka Marks World Cleanup Day 2026 in France with "Find the Unseen" Cleanup Challenge
Published on 09/21/2026 at 04:05, 2 hours 15 minutes ago

UD Info DB Series SSD Drives Achieve FIPS 140-3 Validation
Published on 09/21/2026 at 01:56, 4 hours 24 minutes ago

EQS-Adhoc: Dexus Finance Pty Limited: Change to Leadership Team
Published on 09/20/2026 at 15:10, 15 hours 10 minutes ago

MSITEK Participates in New York Fashion Week Retail Innovation Lab
Published on 09/20/2026 at 09:05, 21 hours 15 minutes ago

Huawei Digital Power Showcases Multi-Scenario Solutions Featuring Grid Forming and AI at IDEE 2026

View all EQS

Published on 09/18/2026 at 18:34, 2 days 11 hours ago

Disclosure of transactions in own shares from September 14 to September 18, 2026
Published on 09/18/2026 at 18:34, 2 days 11 hours ago

Déclaration hebdomadaire d'opérations effectuées du 14 au 18 septembre 2026
Published on 09/18/2026 at 18:10, 2 days 12 hours ago

Rapport semestriel 2026
Published on 09/18/2026 at 17:45, 2 days 12 hours ago

Press Release_Carrefour Bond_September 2026
Published on 09/18/2026 at 17:45, 2 days 12 hours ago

Communiqué de presse_Carrefour Bond_Septembre 2026

View all LES ECHOS COMFI WIRE

News